Search – Page 140 – Indianapolis Business Journal

Home » Search

Articles

FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization

March 31, 2017

Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.

Records for April 3-9, 2017

March 31, 2017

Here are the records listings for April 3-9, 2017.

SMITH: Nation will be watching Indiana Senate race

April 5, 2017

To keep his seat, Joe Donnelly will need to navigate issues and votes such as the confirmation of Supreme Court nominee Neil Gorsuch and reforming the U.S. Environmental Protection Agency in a way that holds his base and left-leaning donors while not offending too many Hoosier voters.

Lilly among firms pulling ads from ‘O’Reilly Factor’

April 5, 2017

A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.

Blame game over drug prices escalates with new ad campaign

April 7, 2017

Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.

Angie’s List discontinues ‘O’Reilly Factor’ advertising

April 7, 2017

The Indianapolis-based consumer-reviews service had been an outlier among major companies in sticking with the show despite a report in The New York Times that Bill O’Reilly and Fox News had settled a rash of cases accusing him of harassment and inappropriate conduct.

Lilly’s rheumatoid arthritis pill rejected by regulators

April 14, 2017

The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.

Wall Street punishes Lilly for latest drug setback; analysts grasp for answers

April 17, 2017

News that federal regulators rejected Lilly’s drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.

Lilly uses ‘horny goat weed’ to fend off Cialis royalty demands

April 18, 2017

Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.

RICKS: Tax reform would deliver Hoosier jobs

April 20, 2017

Lilly would be investing even more here if the U.S. House Republican blueprint for tax reform were already in place. So would the nearly 8,600 Indiana companies that sell products in foreign markets.

Local life sciences, pharma consultancy acquired by German firm

April 24, 2017

Safis Solutions LLC, a 15-year-old Indianapolis consulting firm that helps life science companies move their products through the government regulatory process, has been acquired by PharmaLex, the companies announced Monday.

Lilly profit climbs 18 percent after one-time expenses

April 25, 2017

The Indianapolis-based drugmaker beat Wall Street expectations by 2 cents a share—performance it attributed to brisk sales of new products.

Lilly diabetes drug Jardiance falls short of quarterly sales predictions

April 25, 2017

Shares in Eli Lilly and Co. stock fell more than 3 percent Tuesday after the Indianapolis-based drugmaker released a quarterly earnings report that showed sales of potential blockbuster drug Jardiance missed expectations by a wide margin.

Career includes IT, restaurants and more

April 27, 2017

Clyde Harris says he’s had the “craziest career you have ever seen, from politics to acting in front of the camera to writing scripts to sales.”

Biz interests mostly pleased with legislative session

April 28, 2017

Although lawmakers OK’d less than half the $50 million annual pledge business leaders wanted for expanding state-funded preschool, they passed a major infrastructure bill that businesses favored.

Despite setbacks, top Lilly researcher bullish on pipeline’s momentum

April 28, 2017

The Indianapolis drugmaker is trying to reassure Wall Street that its pipeline is still poised to deliver.

Flooding from rains prompts closure of Indianapolis monument

May 4, 2017

Days of heavy rainfall have forced the temporary closure of downtown Indianapolis’ historic Soldiers and Sailors Monument.

Life sciences firms see some fundraising success but need massive sums

May 4, 2017 | John Russell

Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.

Lilly executive Pescovitz leaving to become university president

May 5, 2017

Oakland University in suburban Detroit on Thursday announced that its board of trustees unanimously chose Ora Hirsch Pescovitz for the job after a search involving more than 60 candidates.

Transcript of April 28, 2017, Life Sciences Power Breakfast panel discussion